ClinicalTrials.govpublic full text
Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA)
ulcerative colitis, prolyl hydroxylase (phd) inhibitor, ulcerative colitis(uc), inflammatory bowel disease (ibd), interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 886532
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.